Sure, Pittsburgh is famous for many things: its sports teams, its rich industrial history, and its bridges, to name a few.

It turns out we had Chet Hanks all wrong. Partly because of his rap career and reality TV appearances, and partly because his ...

The ‘Off Campus’ star also dishes on how filming for season two of the hockey romance series is going: “I'm there pretty much ...

Following an examination of clinical evidence and stakeholder input, Canada's Drug Agency (CDA-AMC) has recommended BIMZELX® (bimekizumab injection) for reimbursement with conditions for patients with ...

OAKVILLE, ON, June 9, 2026 /CNW/ - UCB Canada Inc. today announced that Canada's Drug Agency (CDA-AMC) has issued a positive recommendation to reimburse BIMZELX® (bimekizumab injection) with ...

Bimzelx is a brand-name biologic medication used to treat plaque psoriasis and other conditions by blocking specific immune system proteins that cause inflammation. More common side effects of Bimzelx ...

Don’t be surprised if Survivor opts out of doing another live finale, because host Jeff Probst accidentally spoiled the show last night. The moment went down when Jeff was introducing the final ...

UCB (UCBJY) announced on Tuesday that its biologic medicine Bimzelx outperformed AbbVie’s (ABBV) immunology therapy Skyrizi in a head-to-head trial for psoriatic arthritis, an inflammatory condition ...

BIMZELX is the first approved biologic therapy to demonstrate superior, head-to-head ACR50 joint outcomes in psoriatic arthritis: 49.1% of those receiving BIMZELX vs 38.4% receiving risankizumab ...

Doctors prescribe Bimzelx (bimekizumab-bkzx) for several conditions in adults. Common side effects of the drug include headaches, fatigue, and reactions at the injection site. Serious side effects of ...

Belgian biopharma company UCB (UCBJY) announced on Wednesday that its arthritis therapy Bimzelx outperformed AbbVie’s (ABBV) immunology therapy Skyrizi in a head-to-head trial for psoriatic arthritis, ...

NEW YORK--(BUSINESS WIRE)--Simulmedia, the pioneer of data-driven, audience-based television advertising, today announced the appointment of Justin Nesci as Chief Commercial Officer. Nesci, a seasoned ...